Antibiotic sensitivity of environmental Legionella pneumophila strains isolated in Poland

Introduction and Objective. Legionella bacteria are commonly found in natural aquatic environments such as rivers, lakes, ponds and hot springs. Legionella infection occurs through the inhalation of water-air aerosol generated, for example, by showers or hot tubs. The most common species responsible for infection is Legionella pneumophila, which can cause Pontiac fever, and Legionnaires’ disease, as well as a rare extrapulmonary form. The aim of the study’s is to assess the susceptibility of Legionella pneumophila bacteria isolated from water systems of public buildings in Poland to antibiotics and chemotherapeutic agents used in the treatment of Legionellosis pneumonia. Materials and method. A total of 100 L. pneumophila strains isolated from public buildings, such as hospitals and water recreation facilities, were used for the study. The drug sensitivity of the following antibiotics was determined: erythromycin, azithromycin, ciprofloxacin, levofloxacin, rifampicin, trimethoprim-sulfamethoxazole and tetracycline. Mean MIC50 and MIC90 values were read using accepted standards. Results. The highest mean MIC value was obtained for tetracycline 6,130+/-0,353 μg/ml (with a range from 1,500 μg/ml to 16,000 μg/ml. In contrast, the lowest MIC was recorded with rifampicin: 0.020+/-0.037 μg/ml (with a range from 0.016 μg/ml to 0.380 μg/ml). Conclusions. The lowest biocidal concentration was found for levofloxacin, the highest for tetracycline. The highest MIC50 and MIC90 values were found for tetracycline and the lowest for rifampicin. The highest biocidal values were found for azithromycin and the lowest for tetracycline.

[1]  A. Vantarakis,et al.  Surveillance of Legionella spp. in Open Fountains: Does It Pose a Risk? , 2022, Microorganisms.

[2]  B. Breza-Boruta,et al.  Legionellosis risk—an overview of Legionella spp. habitats in Europe , 2022, Environmental Science and Pollution Research.

[3]  J. Carratalá,et al.  Legionnaires’ Disease: Update on Diagnosis and Treatment , 2022, Infectious Diseases and Therapy.

[4]  C. Montagnese,et al.  Overview of the Clinical and Molecular Features of Legionella Pneumophila: Focus on Novel Surveillance and Diagnostic Strategies , 2022, Antibiotics.

[5]  A. Doménech-Sánchez,et al.  Determination of Legionella spp. prevalence in Spanish hotels in five years. Are tourists really at risk? , 2022, Travel medicine and infectious disease.

[6]  N. Miyashita Atypical pneumonia: Pathophysiology, diagnosis, and treatment. , 2021, Respiratory investigation.

[7]  M. Scaturro,et al.  Antibiotic Susceptibility of Environmental Legionella pneumophila Strains Isolated in Northern Italy , 2021, International journal of environmental research and public health.

[8]  Xiaoxiao Wu,et al.  Early Detection of Legionella pneumophila and Aspergillus by mNGS in a Critically Ill Patient With Legionella Pneumonia After Extracorporeal Membrane Oxygenation Treatment: Case Report and Literature Review , 2021, Frontiers in Medicine.

[9]  B. Kowalczyk,et al.  Budowa IV systemu sekrecji Legionella pneumophilai jego znaczenie w patogenezie , 2021, Postępy Higieny i Medycyny Doświadczalnej.

[10]  Deepika Chauhan,et al.  Pathogenicity and Virulence of Legionella: Intracellular replication and host response , 2021, Virulence.

[11]  K. Sands,et al.  Legionella antimicrobial sensitivity testing: comparison of microbroth dilution with BCYE and LASARUS solid media , 2020, The Journal of antimicrobial chemotherapy.

[12]  O. Pappa,et al.  Antibiotic Resistance of Legionella pneumophila in Clinical and Water Isolates—A Systematic Review , 2020, International journal of environmental research and public health.

[13]  J. Martel,et al.  In Vitro and Intracellular Activities of Omadacycline against Legionella pneumophila , 2020, Antimicrobial Agents and Chemotherapy.

[14]  C. Buchrieser,et al.  Legionnaires' Disease: State of the Art Knowledge of Pathogenesis Mechanisms of Legionella. , 2020, Annual review of pathology.

[15]  K. Keedy,et al.  Efficacy of Delafloxacin versus Moxifloxacin against Bacterial Respiratory Pathogens in Adults with Community-Acquired Bacterial Pneumonia (CABP): Microbiology Results from the Delafloxacin Phase 3 CABP Trial , 2019, Antimicrobial Agents and Chemotherapy.

[16]  R. Chaudhry,et al.  Antibiotic susceptibility of environmental Legionella pneumophila isolated in India. , 2019, Future microbiology.

[17]  M. Höfle,et al.  Antimicrobial agent susceptibilities of Legionella pneumophila MLVA-8 genotypes , 2019, Scientific Reports.

[18]  R. Chaudhry,et al.  Legionella and Legionnaires' disease: Time to explore in India , 2018, Indian journal of medical microbiology.

[19]  M. Montagna,et al.  Environmental surveillance and in vitro activity of antimicrobial agents against Legionella pneumophila isolated from hospital water systems in Campania, South Italy: a 5‐year study , 2018, Environmental research.

[20]  K. Tateda,et al.  In vitro activity of various antibiotics against clinical strains of Legionella species isolated in Japan. , 2018, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

[21]  X. Charpentier,et al.  KKL-35 Exhibits Potent Antibiotic Activity against Legionella Species Independently of trans-Translation Inhibition , 2017, Antimicrobial Agents and Chemotherapy.

[22]  M. Kozioł-Montewka,et al.  Assessment of antibiotic susceptibility of Legionella pneumophila isolated from water systems in Poland. , 2017, Annals of agricultural and environmental medicine : AAEM.

[23]  J. Powis,et al.  Legionella pneumonia in the Niagara Region, Ontario, Canada: a case series , 2016, Journal of Medical Case Reports.

[24]  C. Napoli,et al.  Antibiotic susceptibility of Legionella pneumophila strains isolated from hospital water systems in Southern Italy. , 2015, Environmental research.